Doğan rejected 6,200 doses of the “Johnson & Johnson” vaccine, which became the third vaccine of its kind that received emergency use from the US Food and Drug Administration at the end of last week.
The mayor said the city received 29,000 doses of the “Pfizer-Biontech” and “Moderna” vaccine this week, and that this vaccine is enough to vaccinate every eligible resident who wants to be vaccinated so far.
Residents aged 50 and over with certain illnesses, manufacturing workers, school workers and others classified in high priority groups are currently eligible for the COVID-19 vaccine, according to the Detroit Health Department.
Despite Johnson & Johnson describing the vaccine as “very good”, Dougan said on Thursday he would do his best “to ensure that Detroit residents get the best”.
Clinical trials of both “Moderna” and “Pfizer” vaccines showed their effectiveness in preventing moderate to severe cases of Covid-19 by about 95 percent after taking two doses two weeks apart. The efficacy of the “Johnson & Johnson” vaccine, which required a single dose, was less than that.
Dugan stated that Detroit can establish a center to receive the Johnson & Johnson vaccine later in March or April if needed. He stressed, however, that he does not expect this to happen “in the next two weeks”.
American public health experts are talking about the safety and efficacy of three vaccines approved by the Food and Drug Administration to prevent Covid-19 and encourage people to take any vaccine available to them.
Bob Wheaton, spokesperson for the Michigan Department of Health and Human Services, told CNN on Friday that Johnson & Johnson doses not used by Detroit were given to other health departments with lower coverage rates for users. 65 years and older. “
More than 101,000 vaccine doses have been delivered in the city so far, and more than 55,000 future doses are already planned, according to Covid-19 data in Detroit.